Castration-sensitive Prostate Cancer Market Set to Surge with 13.2% CAGR from 2020 to 2034 The castration-sensitive prostate cancer market is anticipated to grow significantly, driven by advancements in treatment and increasing patient demographics leading to 13.2% CAGR through 2034.

Castration-sensitive Prostate Cancer Market Set to Surge with 13.2% CAGR from 2020 to 2034 #None #ProstateCancer #CSPCMarket #EmergingTherapies